MAINES, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 106
EU - Europa 97
AS - Asia 77
SA - Sud America 7
AF - Africa 2
OC - Oceania 1
Totale 290
Nazione #
US - Stati Uniti d'America 106
CN - Cina 33
GB - Regno Unito 32
SG - Singapore 28
SE - Svezia 15
IE - Irlanda 12
RU - Federazione Russa 10
DE - Germania 8
IT - Italia 8
HK - Hong Kong 7
BR - Brasile 6
FR - Francia 6
FI - Finlandia 4
JP - Giappone 2
KR - Corea 2
NL - Olanda 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
ID - Indonesia 1
IN - India 1
MA - Marocco 1
MW - Malawi 1
NZ - Nuova Zelanda 1
VE - Venezuela 1
Totale 290
Città #
Southend 31
Chandler 19
Dublin 12
Ann Arbor 11
Dallas 11
Singapore 11
Houston 10
Woodbridge 10
Beijing 8
Hong Kong 7
Jinan 6
Ashburn 5
Lawrence 3
Nanjing 3
Princeton 3
Verona 3
Düsseldorf 2
Hangzhou 2
Hebei 2
Seattle 2
Seoul 2
Sindelfingen 2
Tokyo 2
Amsterdam 1
Binzhou 1
Buckeye 1
Casablanca 1
Changsha 1
Columbus 1
Coro 1
Dubai 1
Duncan 1
Fairfield 1
Haikou 1
Hanoi 1
Ho Chi Minh City 1
Itajaí 1
Jakarta 1
Kemerovo 1
Lanzhou 1
Lilongwe 1
Mumbai 1
Munich 1
Norwalk 1
Oklahoma City 1
Piratuba 1
Porto Alegre 1
Portão 1
Puxian 1
Redwood City 1
Santa Clara 1
Schroeder 1
Secaucus 1
Shenyang 1
São Sebastião 1
Tianjin 1
Trento 1
Turku 1
Wilmington 1
Totale 203
Nome #
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 116
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers 99
Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer 78
Totale 293
Categoria #
all - tutte 1.176
article - articoli 1.176
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 2 5 3 1 0 0 1 0 0 0
2021/202218 1 3 0 3 2 0 0 1 1 1 0 6
2022/202356 4 5 5 6 4 17 0 7 6 0 2 0
2023/202425 1 2 2 2 4 2 0 3 1 2 6 0
2024/202568 4 3 3 9 3 3 0 1 16 1 5 20
2025/202626 10 14 2 0 0 0 0 0 0 0 0 0
Totale 293